News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
749,626 Results
Type
Article (44590)
Company Profile (467)
Press Release (704554)
Multimedia
Podcasts (145)
Webinars (23)
Section
Business (209672)
Career Advice (2091)
Deals (36257)
Drug Delivery (140)
Drug Development (84191)
Employer Resources (175)
FDA (16822)
Job Trends (15250)
News (354983)
Policy (33356)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2696)
Accelerated approval (54)
Adcomms (31)
Allergies (179)
Alliances (51147)
ALS (223)
Alzheimer's disease (1871)
Antibody-drug conjugate (ADC) (504)
Approvals (17192)
Artificial intelligence (717)
Autoimmune disease (323)
Automation (57)
Bankruptcy (374)
Best Places to Work (11853)
BIOSECURE Act (20)
Biosimilars (228)
Biotechnology (325)
Bladder cancer (204)
Brain cancer (77)
Breast cancer (789)
Cancer (6142)
Cardiovascular disease (505)
Career advice (1777)
Career pathing (45)
CAR-T (349)
CDC (60)
Celiac Disease (3)
Cell therapy (962)
Cervical cancer (49)
Clinical research (72957)
Collaboration (2208)
Company closure (5)
Compensation (1441)
Complete response letters (93)
COVID-19 (2820)
CRISPR (118)
C-suite (1205)
Cystic fibrosis (163)
Data (8272)
Decentralized trials (3)
Denatured (46)
Depression (176)
Dermatology (93)
Diabetes (607)
Diagnostics (7030)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (353)
Drug pricing (214)
Drug shortages (32)
Duchenne muscular dystrophy (308)
Earnings (93481)
Editorial (70)
Employer branding (21)
Employer resources (154)
Events (123816)
Executive appointments (1130)
FDA (20671)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1827)
Gene editing (257)
Generative AI (59)
Gene therapy (792)
GLP-1 (1113)
Government (4857)
Grass and pollen (6)
Guidances (412)
Healthcare (19465)
HIV (84)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (105)
Immunology and inflammation (323)
Immuno-oncology (105)
Indications (198)
Infectious disease (3177)
Inflammatory bowel disease (229)
Inflation Reduction Act (17)
Influenza (140)
Intellectual property (303)
Interviews (329)
IPO (16963)
IRA (54)
Job creations (3724)
Job search strategy (1473)
JPM (67)
Kidney cancer (19)
Labor market (104)
Layoffs (600)
Leadership (42)
Legal (8046)
Liver cancer (104)
Longevity (34)
Lung cancer (810)
Lymphoma (445)
Machine learning (61)
Management (59)
Manufacturing (1097)
MASH (208)
Medical device (14111)
Medtech (14244)
Mergers & acquisitions (20558)
Metabolic disorders (1601)
mRNA (240)
Multiple sclerosis (197)
NASH (20)
Neurodegenerative disease (460)
Neuropsychiatric disorders (115)
Neuroscience (3492)
Neurotech (1)
NextGen: Class of 2026 (6797)
Non-profit (4621)
Now hiring (79)
Obesity (756)
Opinion (316)
Ovarian cancer (233)
Pain (266)
Pancreatic cancer (320)
Parkinson's disease (392)
Partnered (34)
Patents (613)
Patient recruitment (712)
Peanut (63)
People (61198)
Pharmaceutical (79)
Pharmacy benefit managers (34)
Phase 1 (22952)
Phase 2 (32198)
Phase 3 (23759)
Pipeline (9191)
Policy (340)
Postmarket research (2611)
Preclinical (9851)
Press Release (67)
Prostate cancer (323)
Psychedelics (64)
Radiopharmaceuticals (356)
Rare diseases (1166)
Real estate (6089)
Recruiting (71)
Regulatory (26083)
Reports (56)
Research institute (2523)
Resumes & cover letters (359)
Rett syndrome (39)
RNA editing (27)
RSV (88)
Schizophrenia (188)
Series A (309)
Series B (227)
Service/supplier (11)
Sickle cell disease (121)
Special edition (29)
Spinal muscular atrophy (171)
Sponsored (49)
Startups (3838)
State (2)
Stomach cancer (19)
Supply chain (132)
Tariffs (89)
The Weekly (96)
Vaccines (1149)
Venture capital (120)
Weight loss (491)
Women's health (132)
Worklife (21)
Date
Today (25)
Last 7 days (622)
Last 30 days (3350)
Last 365 days (30935)
2026 (14041)
2025 (31072)
2024 (36292)
2023 (41032)
2022 (52290)
2021 (56771)
2020 (54967)
2019 (47475)
2018 (35752)
2017 (33052)
2016 (32398)
2015 (38438)
2014 (32219)
2013 (27146)
2012 (29263)
2011 (29914)
2010 (28046)
Location
Africa (770)
Alabama (99)
Alaska (7)
Arizona (361)
Arkansas (16)
Asia (41304)
Australia (6891)
California (13780)
Canada (3858)
China (1438)
Colorado (588)
Connecticut (608)
Delaware (418)
Europe (90948)
Florida (2036)
Georgia (440)
Hawaii (3)
Idaho (63)
Illinois (1103)
India (93)
Indiana (617)
Iowa (25)
Japan (563)
Kansas (135)
Kentucky (52)
Louisiana (45)
Maine (76)
Maryland (1640)
Massachusetts (9953)
Michigan (374)
Minnesota (745)
Mississippi (6)
Missouri (147)
Montana (35)
Nebraska (29)
Nevada (145)
New Hampshire (89)
New Jersey (3619)
New Mexico (32)
New York (3581)
North Carolina (1804)
North Dakota (10)
Northern California (6918)
Ohio (409)
Oklahoma (23)
Oregon (44)
Pennsylvania (2742)
Puerto Rico (29)
Rhode Island (51)
South America (1131)
South Carolina (86)
South Dakota (2)
Southern California (5414)
Tennessee (216)
Texas (2185)
United States (48689)
Utah (408)
Vermont (1)
Virginia (332)
Washington D.C. (82)
Washington State (1126)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
749,626 Results for "black diamond therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference 2026
May 24, 2026
·
1 min read
Press Releases
Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7, 2026
·
6 min read
Press Releases
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
May 22, 2026
·
7 min read
Press Releases
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
May 19, 2026
·
1 min read
Press Releases
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - March 2, 2026
March 3, 2026
·
1 min read
Press Releases
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting
April 21, 2026
·
5 min read
Press Releases
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 16, 2026
·
7 min read
Press Releases
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - November 6, 2025
November 6, 2025
·
1 min read
Press Releases
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 7, 2025
·
6 min read
Deals
Servier Nabs Solid Tumor Asset in up to $780M Deal With Black Diamond
The French pharma is getting Black Diamond’s de-prioritized molecule for non-small cell lung cancers with specific mutations whose development had been paused to save money.
March 19, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 74,963
Next
